InVivo Therapeutics Holdings Corp. (NVIV) announced today that
Mark Perrin, Chief Executive Officer, is scheduled to present at the
2014 Aegis Healthcare Conference to be held September 10-13, 2014 at The
Encore at Wynn Las Vegas. The Company’s presentation will be on
Thursday, September 11th at 10:00 a.m. PDT.
Mr. Perrin said, “InVivo has been through many important,
transformational changes since the beginning of the year. I’m excited to
tell the story of a streamlined and focused company with a clear path
forward towards achieving our goal of developing effective therapies for
spinal cord injury. This meeting is an important component of our
expanding outreach to the investor, scientific and patient communities
in order to establish ourselves as a leader in the spinal cord injury
space.”
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and
biotechnology company with a focus on treatment of spinal cord injuries.
The company was founded in 2005 with proprietary technology co-invented
by Robert Langer, ScD., Professor at Massachusetts Institute of
Technology, and Joseph P. Vacanti, MD, who is affiliated with
Massachusetts General Hospital. In 2011 the company earned the David S.
Apple Award from the American Spinal Injury Association for its
outstanding contribution to spinal cord injury medicine. The
publicly-traded company is headquartered in Cambridge, MA. For more
details, visit, www.invivotherapeutics.com.
Copyright Business Wire 2014